FDA brags about its massive systems of data collection, learns nothing from them?

Robert Roos News Editor Oct 23, 2008 (CIDRAP News) – The federal Advisory Committee on Immunization Practices (ACIP) has opened the door to voluntary anthrax vaccination for first responders, revising an 8-year-old recommendation against that step. The committee, meeting yesterday, said the risk of anthrax exposure for emergency responders is low but “may not be…
The Boston bombing case was horrific and unexplainable, unpardonable. Yet the public lacks much evidence about it and no trial has taken place. Where is the evidence the brothers made the bombs? What is Dzhokhar’s side of the story? Have you heard it? One brother is dead and the other has been under wraps since…
by Brian McFadden for Daily Kos A compendium of comments on the new statin guidelines from Gary Schwitzer at Health News Review: I’d like to see a public survey of comprehension of the recent splash of news about new guidelines for heart disease prevention and statin drug use. Heads must be spinning.Here are some of the pieces…
Katherine Sebelius, Secretary of the US Department of Health and Human Services (HHS), has proposed testing anthrax vaccine in children—ostensibly to protect American children in the unlikely event of an anthrax attack.[1] But no credible evidence of an impending anthrax threat has ever been cited. The only US anthrax threat, in 2001, was traced by…
Thanks to Teresa Binstock for this tip– An exposure to nano-scale copper oxide particles stunted the shoots and roots of radishes and two species of rye grass.
It is the darnedest thing. The UK government flat out admits it has been lying to the public, but in such a bland manner that it is not at all clear why the official government numbers suddenly shifted. And they didn’t shift a little. Covid hospitalizations declined by 50%. The way this is being presented…
Comments are closed.
'The Biopharmaceutical Industry Provides 75% Of The FDA's Drug Review Budget. Is This A Problem?'
https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/?sh=156c1b5449ec